We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
-2.46%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$14.7B
AUM Growth
-$1.06B
(-6.7%)
Cap. Flow
-$361M
Cap. Flow
% of AUM
-2.46%
Top 10 Holdings %
Top 10 Hldgs %
21.8%
Holding
258
New
31
Increased
101
Reduced
86
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$92.1M |
| 2 |
M/I Homes
MHO
|
+$90.4M |
| 3 |
AXON
Axon Enterprise
AXON
|
+$88.8M |
| 4 |
Apollo Global Management
APO
|
+$69.1M |
| 5 |
GE HealthCare
GEHC
|
+$56.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Icon
ICLR
|
+$207M |
| 2 |
WCC
WESCO International
WCC
|
+$106M |
| 3 |
WIRE
Encore Wire Corp
WIRE
|
+$90.1M |
| 4 |
Cisco
CSCO
|
+$80.9M |
| 5 |
HubSpot
HUBS
|
+$65.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.73% |
| 2 | Healthcare | 19.11% |
| 3 | Industrials | 15.83% |
| 4 | Consumer Discretionary | 11.82% |
| 5 | Financials | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Avient
AVNT
$4.19B
| $33.5M | 0.23% |
949,317
+60,795
| +7% | +$2.35M |
|
152
Essex Property Trust
ESS
$18.5B
| $31.8M | 0.22% |
149,886
-6,275
| -4% | -$1.47M |
|
153
SentinelOne
S
$7.34B
| $31.8M | 0.22% |
1,885,443
+118,276
| +7% | +$1.87M |
|
|
MDRX
154
DELISTED
Veradigm Inc. Common Stock
MDRX
| $31.6M | 0.22% |
2,401,754
+165,642
| +7% | +$2.17M |
|
155
Calix
CALX
$2.39B
| $31.1M | 0.21% |
679,187
+147,785
| +28% | +$6.69M |
|
156
Marqeta
MQ
$1.66B
| $30.3M | 0.21% |
+1,268,689
| New | +$28.8M |
|
157
Halliburton
HAL
$26.6B
| $30.3M | 0.21% |
748,936
-28,537
| -4% | -$1.12M |
|
158
StepStone Group
STEP
$3.82B
| $28.8M | 0.2% |
913,069
+41,217
| +5% | +$1.2M |
|
159
Universal Display
OLED
$4.19B
| $27.8M | 0.19% |
177,304
-32,699
| -16% | -$4.97M |
|
160
Innoviva
INVA
$1.48B
| $26.6M | 0.18% |
2,045,010
+127,759
| +7% | +$1.66M |
|
|
CHX
161
DELISTED
ChampionX
CHX
| $25M | 0.17% |
700,453
+50,348
| +8% | +$1.79M |
|
162
STAG Industrial
STAG
$7.19B
| $23.9M | 0.16% |
691,212
+37,274
| +6% | +$1.35M |
|
163
Kulicke & Soffa
KLIC
$4.78B
| $23.7M | 0.16% |
487,571
+119,380
| +32% | +$6.33M |
|
164
Super Micro Computer
SMCI
$20.1B
| $23.5M | 0.16% |
+856,620
| New | +$23.9M |
|
165
MoonLake Immunotherapeutics
MLTX
$1.55B
| $22.3M | 0.15% |
391,279
-18,840
| -5% | -$1.04M |
|
166
Palomar
PLMR
$3.45B
| $22M | 0.15% |
433,346
+89,410
| +26% | +$4.89M |
|
|
CERE
167
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $21.3M | 0.14% |
974,483
+398,949
| +69% | +$9.98M |
|
|
APLS
168
DELISTED
Apellis Pharmaceuticals
APLS
| $20.9M | 0.14% |
548,870
-47,362
| -8% | -$2.08M |
|
169
Broadcom
AVGO
$2.04T
| $20.7M | 0.14% |
249,780
+8,900
| +4% | +$771K |
|
|
ETNB
170
DELISTED
89bio
ETNB
| $20.3M | 0.14% |
1,311,886
+476,655
| +57% | +$8M |
|
|
WCC
171
WESCO International
WCC
$17.7B
| $16.9M | 0.11% |
117,245
-653,892
| -85% | -$106M |
|
172
CRISPR Therapeutics
CRSP
$5.17B
| $13.5M | 0.09% |
+297,550
| New | +$15.4M |
|
173
Plexus
PLXS
$7.23B
| $13.3M | 0.09% |
+142,815
| New | +$13.8M |
|
174
IBM
IBM
$224B
| $12.7M | 0.09% |
90,209
+5,394
| +6% | +$767K |
|
175
Camtek
CAMT
$7.25B
| $12.1M | 0.08% |
+194,237
| New | +$9.59M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Westfield Capital Management held 258 positions worth $14.7B, down 6.7% from $15.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Westfield Capital Management's Q3 2023 filing shows 31 new, 101 increased, 86 reduced and 24 closed positions. Its largest new stake was M/I Homes: 977,922 shares worth $82.2M. The largest sale was Icon, an estimated $207M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.
- Westfield Capital Management's largest Q3 2023 buy was M/I Homes: 977,922 shares worth $82.2M.
- Westfield Capital Management added most to DexCom in Q3 2023, an estimated $92.1M increase.
- Westfield Capital Management's biggest Q3 2023 reduction was Icon, cutting an estimated $207M.
- Westfield Capital Management fully exited Encore Wire Corp in Q3 2023, selling an estimated $90.1M.
- Westfield Capital Management's ten largest holdings make up 22% of its $14.7B portfolio in Q3 2023.
- Westfield Capital Management opened 31 new positions and closed 24 in Q3 2023.
- Westfield Capital Management's portfolio value fell 6.7% quarter-over-quarter to $14.7B.
Based on Westfield Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.